Stocks/Funds/CIK 872589

REGENERON PHARMACEUTICALS, INC.

microcap filerlong-term holderconcentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 872589
Assets
$48M
-96.1% YoY
Holdings
2
Lifetime alpha vs market
+83.97% annual
Average hold time
1.5 yr
median 1.5 yr

Quarterly history

Cum return +141% vs S&P +13% · α +129% lifetimeAUM $48M · peak $1.5BFlow $-0M (-0%)2024-122025-032025-062025-092025-122026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
-3.84%
trims when stocks drop
when a holding falls −10%+
Middle response
Rally response
-16.66%
trims into rallies
when a holding rises +10%+

Top positions · 2

Ticker$ value% portYoYHold time
NTLAIntellia Therapeutics, I$47M99.1%+80.3%1.5 yr
ACETAdicet Bio, Inc.$0M0.9%-43.6%1.5 yr

Portfolio composition (YoY)

Industry mix
Biotechnology100.0%+0.1pp$48M
Country
US100.0%+0.1pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %
NTLA$26M+0.02B80.3%
ACET$1M-0.01B-43.6%

Losers

TickerPrev $PnLYoY %
ACET$1M-0.01B-43.6%

Top buys this quarter · 0

No buys this quarter

Top sells this quarter · 0

No sells this quarter

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$48M2+115.06%+17.59%+97.46%-0.00B
2025-12-31$34M2+70.25%+17.72%+52.54%-0.59B
2025-09-30$700M4+40.82%+8.12%+32.70%-1.39B
2025-06-30$1.49B4+20.62%+10.78%+9.85%-0.00B
2025-03-31$1.23B6+12.16%-4.27%+16.43%+0.01B
2024-12-31$1.09B6